LDS/Medical Tests/MAML2 (11q21) Rearrangement, FISH, Tissue

MAML2 (11q21) Rearrangement, FISH, Tissue

The mastermind-like 2 (MAML2) gene is formed by the translocations t(11;19)(q21;p13) or t(11;15)(q21;p26). The fusion of this gene with other gene(s) are responsible for neoplastic changes in glandular tissues. CREB-regulated transcription co-activator (CRTC) 1-MAML2 and CRTC3-MAML2 fusion genes are associated with mucoepidermoid carcinoma of the salivary gland. Around 40-80% and 5% of the cases of mucoepidermoid carcinoma exhibit CRTC1-MAML2 and CRTC3-MAML2 fusion respectively.

Mucoepidermoid carcinoma (MEC) represents approximately 5% of salivary gland tumors and 20% of salivary malignancies. Other subtypes include adenoid cystic carcinoma and epithelial-myoepithelial carcinoma. Squamous cells, goblet mucin-secreting cells, and cells of intermediate type are all present in mucoepidermoid carcinoma. While evaluation for MAML2 rearrangements by fluorescence in-situ hybridization (FISH) is not required for routine diagnosis it may be useful in mucin-poor or oncocytic MEC when the diagnosis is in question. The fusion genes are occasionally associated with hidradenoma, an adnexal tumor of the apical sweat gland.

  • Diagnosis of mucoepidermoid carcinoma of salivary gland
  • Treatment selection and disease management

Positive or abnormal:

if neoplastic clone carrying the MAML2 rearrangement is detected if the percentage of cells with a clonal rearrangement exceed the normal cells or the cutoff for the MAML2 probe. A positive result is highly suggestive of a diagnosis of mucoepidermoid carcinoma.

A negative result suggests no rearrangement of the MAML2 gene region at 11q21 indicating a diagnosis of mucoepidermoid carcinoma is less likely but not excluded.

Negative, no rearrangement of the MAML2 gene region was identified

FISH (Fluorescence In-situ Hybridization).

FFPE (Formalin fixed paraffin embedded) tissue.

Stability

  • FFPE is stable at room temperature indefinitely.
Salivary gland biopsy, hematoxylin and eosin staining, immunohistochemistry (IHC), AREG expression test, serum amylase.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login